วีดีโอ

Mtiuo brirasil 🙋 adelaide 02 30 2024 sex fev i t c d e u a n o 2024sgtoflasicune 1:31

I saw some problems on your TH-cam channel, can I tell you that? If you want, I can tell you, due to all the problems, your TH-cam channel's video views and subscribers are not increasing.

Impressive range of activities and services ! Well done 👏

At 1:36 wtf is that pic about. Aren't you guys with CYM? This is just spray adrenochrome. You're connected to bad stuff. I Kno all about you dbags soon the world will too

PЯӨMӨƧM

11lsm6 vun.fyi

I will recommend mr Edwin Clifford for your trades he’s the best any new investor could work with he helped me clear off my mortgage payment and I’m sincerely grateful for his assistance never thought I’d see a day I made thousands from trading. Thanks a lot sir Edwin.

My journey as a trader was not funny at the beginning simply because I was so inexperienced and clueless till I got introduced to a very great trader mr Edwin Clifford and ever since my journey so far has been the smoothest thanks a lot Edwin.

Can you please react to 👉the lady of heaven trailer? ( The movie will be in AMC theaters by the 10th of December in the US and it is expected to have a worldwide release in various countries very shortly after that ) ❤️❤️

Good work keep it up 👍🤠👍

There's no doubt in my mind that we are not only going bull, but BTC is going nuclear. A lot of people are wondering if now is a good time to buy because of where the price is at right now. I'd say it's outrightly wrong to just sit back hodl and wait maybe incur some losses along the line, that's a wrong mindset for an investor because as an investor finding ways to always increase and stack up more coins thereby making prof!ts should be the way of lifeThat being said, the market is still all about BTC at the moment and I’ll advise current investors and newbies to take advantage of Paul Hansen program, a pro trader who runs a training program for investors/newbies who lack understanding on how trading Bitcoin works, to help them recover loss from the crash and also accumulate more bitcoin, with his program i went from having 2.04btc to 8.3btc in just 7 weeks. You can reach Paul on T⊶E⊶L⊶E⊶G⊶R⊶A⊶M (@signalstatistics) let’s make the best of whatever we can…

c12ah vyn.fyi

Agenus Inc. (AGEN) PT Raised to $11 at B.RILEY Current stock price is $6.04 Agenus (ticker symbol AGEN) is an immuno-therapy clinical stage company. They also produce vaccines and cell therapy (INKT’S) through their subsidiary company Agentus. Agenus recently announced the confidential submission for proposed IPO of its subsidiary company, MiNk Therapeutics. Long shareholders are extremely happy to hear this long awaited good news! Their main product and near future revenue generators are their PD-1 and CTLA-4 CPMS. The FDA just recently accepted priority review for the BLA filing of AGEN2034, their PD-1 molecule in second line cervical cancer. They have a PDUFA date set for December 16, 2021. They’re also on track for a BLA filing with their PD-1 and first generation CTLA-4 in combination for the same indication. Agenus will be presenting new data for the combo trial at ESMO In September which the CEO Dr. Armen said he’s “very excited about.” For the record, the CEO doesn’t loosely use the word “excited” unless it’s warranted. Agenus’s PD-1 has shown clinical proof to be differentiated from the other PD-1’s that are already out there on the market; mainly it’s superiority over keytruda (in second line CC). More importantly, Agenus’s PD-1 works in both PD-L1 positive AND negative tumors. Keytruda’s does not. Agenus also has the most powerful adjuvant (QS-21 stimulon) on the market. Not to be confused with the other QS-21’s that are out there. QS-21 stimulon is basically an ingredient that increases the efficacy of a vaccine/drug (COVID-19?) QS-21 stimulon is one of the main reasons why GSK’s shingrix vaccine has taken up most of the market share. Agenus is currently working on getting funding from the government to rapidly increase production. Dr.Armen stated that this will be one of the significant value drivers by the end of the year. Agenus is partnered with Incyte, Merck, Gilead, Glaxosmithkline and most recently, Bristol Myers Squibb. Agenus set a previous record for money given for three preclinical molecules with Gilead for ~150m upfront cash (30m in equity) along with future potential royalties and milestones worth around ~1.7B. However this year, BMY beat that figure by acquiring only one preclinical molecule which is a TIGIT BISPECIFIC to the tune of ~200m along with future potential milestones and royalties worth ~1.36B However, the most exciting molecule they have could be a potential multi blockbuster which is their next generation CTLA-4 AGEN1181. This is what most investors are banking on. It’s currently in phase 2. It was generating partial and complete responses in phase 1 which is very promising ‘cause phase 1 is administered in low dosage to monitor toxicity levels and showing very promising results. Ctla-4 is notorious for being toxic but agenus has manufactured a version that has sustained tolerable toxicity levels. This is huge. They will be presenting data at the next big venue which will either be at ESMO in September or SITC in December. They have a vast pipeline for such a small company. Probably the most robust pipeline out of any company their size. Finally, they have a clinical trial with their INKT cell therapy that’s showing positive signs in patients with severe symptoms from COVID-19. So far, 3 out of 4 patients have been extubated (taken off ventilators) within 24 hours. These trials have been running a little slow but they’re expecting additional clinical data soon. However, COVID-19 is not their primary objective with INKT’s. It was nearly an afterthought during the pandemic. Their INKT’s will mainly target Cancer cells. Final note: institutions have recently taken more of an interest in Agenus. I believe institutional holdings have increased by over 10 percent. Agenus has about ~319m in cash as of last quarter which would give them about roughly 2 years of cash runway. GLTALS

voo.fyi bonzer

Awesome content!! 😁 You deserve more views! Have you checked Promosm!? You should use it to promote your videos and grow your channel.

Very interesting to listen to all members of the panel. My question is regarding VAT ,I work for a lab when selling like PCR kits + analysis to pharmacies and clinics we are not charging any VAT we think we are exempt basically because primarily if the purpose of the test is to protect, maintain and restore the health of a patient and also performed or directly supervised by a healthcare professional we are exempt. On the other hand we pay a lot of input vat on purchases but the fact there is no output VAT so we are not claiming the input VAT. Can somebody advise on that issue please to avoid any problem with HMRC in the future. Many thanks!

Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as a targeted therapy for the treatment of people who has cancer. It represents an innovative therapeutic application that includes the unique, high specificity and antitumor activity of monoclonal antibodies which are tumor-specific but not very cytotoxic, with the cell killing activity of small molecule drugs that are too toxic to be used on their own.www.bocsci.com/antibody-drug-conjugates-services.html

This was an enjoyable networking event with engaging speakers. Thanks for organising!

Useless, can not hear.